CLINICAL TRIALS PROFILE FOR CIPRODEX
✉ Email this page to a colleague
All Clinical Trials for CIPRODEX
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00945802 ↗ | FST-201 In The Treatment of Acute Otitis Externa | Terminated | Shire | Phase 3 | 2009-07-31 | The objective of this study is to evaluate the efficacy of FST-201 compared to Ciprodex in the treatment of acute otitis externa. This trial is designed to enable filing of a New Drug Application in support of FST-201 for the indication of acute otitis externa. |
| NCT00956748 ↗ | N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media | Withdrawn | St. Paul's Hospital, Canada | Phase 4 | 2019-11-29 | Chronic suppurative otitis media (CSOM) can be particularly difficult to treat as a number of patients do not respond to routine antibiotic or surgical treatments. The current treatment involves administering combination antibiotic anti-inflammatory ear drops such as Ciprodex (ciprofloxacin 0.3% / dexamethasone 0.1%). Although most patients experience a relief of symptoms, a fraction of patients remain refractory to treatment. Recent findings suggest that the addition of N-acetylcysteine (0.5-2%) to Ciprodex is a superior treatment for otitis media with effusion compared to the use of Ciprodex alone. |
| NCT00961675 ↗ | FST-201 in the Treatment of Acute Otitis Externa | Completed | Shire | Phase 3 | 2009-08-31 | The objective of this study is to evaluate the efficacy of FST-201 compared to Ciprodex in the treatment of acute otitis externa. This study will be conducted at one site, the Lyndon B. Johnson (LBJ) Tropical Medical Center, Department of Otolaryngology, in Pago Pago, American Samoa. |
| NCT01027494 ↗ | Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora | Completed | Alcon Research | 2009-12-01 | The purpose of this observational study was to evaluate the effects of a topical fluoroquinolone (antibiotic) instilled into the otic (ear) canal to treat Acute Otitis Media through Tympanostomy Tubes (AOMT) on selected bacterial species on the skin near the ear, in the nose, and in the throat. | |
| NCT01359098 ↗ | Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa | Completed | Otic Pharma | Phase 2 | 2011-07-01 | The purpose of this study is to assess the Safety and Efficacy of Ciprodexa Foam (0.3% Ciprofloxacin, 0.1% Dexamethasone Otic Foam), used once-a-day for 7 days for the treatment of Acute Diffuse Otitis Externa, compared to Ciprodex otic suspension used twice daily for 7 days. |
| NCT01908803 ↗ | Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes | Terminated | Alcon Research | Phase 2 | 2013-12-01 | The purpose of this study is to evaluate a single application of AL-60371/AL-817 Otic Suspension relative to ototopical CIPRODEX for sustained clinical cure, microbiological success, and time to cessation of otorrhea. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CIPRODEX
Condition Name
Clinical Trial Locations for CIPRODEX
Trials by Country
Clinical Trial Progress for CIPRODEX
Clinical Trial Phase
Clinical Trial Sponsors for CIPRODEX
Sponsor Name
